- Home
- HYNE vs INO Comparison
HYNE vs INO Comparison
Compare HYNE & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$1.75
Company Overview
Basic Information| Metric | HYNE | INO |
|---|---|---|
| Founded | 2025 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 115.7M | 118.9M |
| IPO Year | N/A | 1999 |
Fundamental Metrics
Financial Performance| Metric | HYNE | INO |
|---|---|---|
| Price | $14.60 | $1.75 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 24.5K | ★ 844.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 35.14 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $42,220,086.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $23,060.18 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 19.37 |
| 52 Week Low | $13.56 | $1.30 |
| 52 Week High | $14.85 | $2.86 |
Technical Indicators
Market Signals| Indicator | HYNE | INO |
|---|---|---|
| Relative Strength Index (RSI) | 55.78 | 52.38 |
| Support Level | $14.01 | $1.72 |
| Resistance Level | $14.85 | $1.78 |
| Average True Range (ATR) | 0.25 | 0.10 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 53.70 | 40.13 |
Price Performance
Historical Comparison HYNE
INO
About HYNE Hoyne Bancorp Inc.
Hoyne Bancorp Inc is a holding company that conducts business mainly through its subsidiaries. It is a savings institution focused on serving customers' banking needs in the market area. The group offers Personal and Business banking services.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.